(Q45081764)

English

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: A class III antiarrhythmic agent without cardiodepressant effects

scientific article published on December 1, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: A class III antiarrhythmic agent without cardiodepressant effects (English)

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

B. S. Stambler

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

S. S. Gottlieb

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

B. N. Singh

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

K. B. Ramanathan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

J. D. Ogilby

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

K. A. Ellenbogen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

language of work or name

0 references

publication date

1 December 1995

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

full work available at URL

https://doi.org/10.1016/0735-1097(95)00376-2

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594103

2 June 2024

https://api.elsevier.com/content/article/PII:0735109795003762?httpAccept=text/xml

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

https://api.elsevier.com/content/article/PII:0735109795003762?httpAccept=text/plain

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1679-1684

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Antiarrhythmic drugs

1

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

2

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction

3

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Hemodynamic and neurohormonal effects of quinidine in patients with severe left ventricular dysfunction secondary to coronary artery disease or idiopathic dilated cardiomyopathy

4

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease

5

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure

6

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.

7

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations

8

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro

9

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Cellular Electrophysiological Effects of the Class III Antiarrhythmic Agents Sematilide and Clofilium on Rabbit Atrial Tissues

13

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs

15

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model

16

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans

18

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Pharmacology of the class 111 antiarrhythmic agent sematilide in patients with arrhythmias

19

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Sudden death in patients with congestive heart failure: future directions

20

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

23

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

24

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Effect of antiarrhythmic drugs on mortality after myocardial infarction

25

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

26

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerationsa

27

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Negative lusitropic effect of DPI 201-106 and E4031. Possible role of prolonging action potential duration.

28

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

The effect of the duration of the action potential on contraction in the mammalian heart muscle

29

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism

30

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Cellular electrophysiological effects of D- and DL-sotalol in guinea-pig sinoatrial node, atrium and ventricle and human atrium: differential tissue sensitivity.

31

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication

32

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Torsade de pointes induced by N-Acetylprocainamide

33

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Sotalol, hypokalaemia, syncope, and torsade de pointes

34

1 reference

10.1016/0735-1097(95)00376-2

https://api.crossref.org/works/10.1016/0735-1097(95)00376-2

2 June 2024

Identifiers

10.1016/0735-1097(95)00376-2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

release_medurkjaazeovnqqfqefm4u2tm

1 reference

https://api.fatcat.wiki/v0/release/medurkjaazeovnqqfqefm4u2tm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45081764&oldid=2170609706"